Brevan Howard Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Sell |
14,754
-52,259
| -78% | -$587K | ﹤0.01% | 1653 |
|
|
2025
Q1 | $306K | Buy |
+67,013
| New | +$306K | ﹤0.01% | 814 |
|
|
2024
Q3 | – | Sell |
-23,782
| Closed | -$116K | – | 1411 |
|
|
2024
Q2 | $116K | Buy |
+23,782
| New | +$116K | ﹤0.01% | 907 |
|
|
2024
Q1 | – | Sell |
-14,741
| Closed | -$205K | – | 1320 |
|
|
2023
Q4 | $205K | Buy |
+14,741
| New | +$205K | ﹤0.01% | 825 |
|